Chiral FexCuySe nanoparticles as peroxidase mimics for colorimetric detection of 3, 4-dihydroxy-phenylalanine enantiomers

Chiral nanoenzymes: synthesis and applications

Chiral nanoenzymes are a new type of material that possesses both chiral nanostructures and enzymatic catalytic activity. These materials exhibit selectivity in their catalytic activity towards organisms due to the introduction of chiral features in nanomaterials and have inherent chiral discrimination in organisms. As synthetic enzymes, chiral nanoenzymes offer significant advantages over natural enzymes. Due to their unique chiral structure and distinctive physicochemical properties, chiral nanoenzymes play an important role in various fields, including biology, medicine, and environmental protection. Their strong stereospecificity and biocompatibility make them useful in disease therapy, biosensing, and chiral catalysis, setting them apart from conventional and natural enzymes. In recent years, the design of synthetic methods and biological applications of chiral nanoenzymes has received significant attention and extensive research among scientists. This paper provides a systematic review of the research progress in the discovery, development, and application of chiral nanoenzymes in the last decade. Additionally, it presents various applications of chiral nanoenzymes, such as disease therapy, biosensing, and chiral catalysis. Finally, the challenges and future prospects of chiral nanoenzymes are discussed.

Applications of Nanozymes in Chiral-Molecule Recognition through Electrochemical and Ultraviolet-Visible Analysis

Chiral molecules have similar physicochemical properties, which are different in terms of physiological activities and toxicities, rendering their differentiation and recognition highly significant. Nanozymes, which are nanomaterials with inherent enzyme-like activities, have garnered significant interest owing to their high cost-effectiveness, enhanced stability, and straightforward synthesis. However, constructing nanozymes with high activity and enantioselectivity remains a significant challenge. This review briefly introduces the synthesis methods of chiral nanozymes and systematically summarizes the latest research progress in enantioselective recognition of chiral molecules based on electrochemical methods and ultraviolet-visible absorption spectroscopy. Moreover, the challenges and development trends in developing enantioselective nanozymes are discussed. It is expected that this review will provide new ideas for the design of multifunctional chiral nanozymes and broaden the application field of nanozymes.

Nanozymes for biomedical applications: Multi-metallic systems may improve activity but at the cost of higher toxicity?

Nanozymes are nanomaterials with intrinsic enzyme-like activity with selected advantages over native enzymes such as simple synthesis, controllable activity, high stability, and low cost. These materials have been explored as surrogates to natural enzymes in biosensing, therapeutics, environmental protection, and many other fields. Among different nanozymes classes, metal- and metal oxide-based nanozymes are the most widely studied. In recent years, bi- and tri-metallic nanomaterials have emerged often showing improved nanozyme activity, some of which even possess multifunctional enzyme-like activity. Taking this concept even further, high-entropy nanomaterials, that is, complex multicomponent alloys and ceramics like oxides, may potentially enhance activity even further. However, the addition of various elements to increase catalytic activity may come at the cost of increased toxicity. Since many nanozyme compositions are currently being explored for in vivo biomedical applications, such as cancer therapeutics, toxicity considerations in relation to nanozyme application in biomedicine are of vital importance for translation. This article is categorized under: Therapeutic Approaches and Drug Discovery > Emerging Technologies Toxicology and Regulatory Issues in Nanomedicine > Toxicology of Nanomaterials Diagnostic Tools > Diagnostic Nanodevices.

Colorimetric discrimination and spectroscopic detection of tyrosine enantiomers based on melamine induced aggregation of l-cysteine/Au nanoparticles

Au nanoparticles (AuNPs) are decorated by l-cysteine (L-Cys), and the resultant chiral L-Cys/AuNPs can be used for colorimetric discrimination and spectroscopic detection of the tyrosine (Tyr) enantiomers. Melamine (Mel) can induce the aggregation of the L-Cys/AuNPs through ligand exchange, leading to a distinct color change from wine red to purple. Owing to the same rotatory direction of L-Cys/AuNPs and L-Tyr, the L-Cys/AuNPs exhibit a significantly higher binding affinity toward L-Tyr than D-Tyr, and thus the Mel induced aggregation of the L-Cys/AuNPs is greatly alleviated by the protection from the L-Tyr protective layer. Therefore, the Tyr enantiomers can be simply discriminated by naked eyes. In addition, the absorbance of the aggregated L-Cys/AuNPs at ∼630 nm increases linearly with decreasing concentrations of L-Tyr ranging from 10 nM to 1 mM due to the weakened protection effect from L-Tyr, and thus spectroscopic detection of L-Tyr can also be accomplished by the developed L-Cys/AuNPs with a limit of detection (LOD) of 5.3 nM.

Emerging potentials of Fe-based nanomaterials for chiral sensing and imaging

Fe-based nanostructures have possessed promising properties that make it suitable for chiral sensing and imaging applications owing to their ultra-small size, non-toxicity, biocompatibility, excellent photostability, tunable fluorescence, and water solubility. This review summarizes the recent research progress in the field of Fe-based nanostructures and places special emphases on their applications in chiral sensing and imaging. The synthetic strategies to prepare the targeted Fe-based structures were also introduced. The chiral sensing and imaging applications of the nanostructures are discussed in details.

Nanozymes with biomimetically designed properties for cancer treatment

Nanozymes, as a type of nanomaterials with enzymatic catalytic activity, have demonstrated tremendous potential in cancer treatment owing to their unique biomedical properties. However, the heterogeneity of tumors and the complex tumor microenvironment pose significant challenges to the in vivo catalytic efficacy of traditional nanozymes. Drawing inspiration from natural enzymes, scientists are now using biomimetic design to build nanozymes from the ground up. This approach aims to replicate the key characteristics of natural enzymes, including active structures, catalytic processes, and the ability to adapt to the tumor environment. This achieves selective optimization of nanozyme catalytic performance and therapeutic effects. This review takes a deep dive into the use of these biomimetically designed nanozymes in cancer treatment. It explores a range of biomimetic design strategies, from structural and process mimicry to advanced functional biomimicry. A significant focus is on tweaking the nanozyme structures to boost their catalytic performance, integrating them into complex enzyme networks similar to those in biological systems, and adjusting functions like altering tumor metabolism, reshaping the tumor environment, and enhancing drug delivery. The review also covers the applications of specially designed nanozymes in pan-cancer treatment, from catalytic therapy to improved traditional methods like chemotherapy, radiotherapy, and sonodynamic therapy, specifically analyzing the anti-tumor mechanisms of different therapeutic combination systems. Through rational design, these biomimetically designed nanozymes not only deepen the understanding of the regulatory mechanisms of nanozyme structure and performance but also adapt profoundly to tumor physiology, optimizing therapeutic effects and paving new pathways for innovative cancer treatment.

Dipeptide-Capped Copper Nanoparticles as Chiral Nanozymes for Colorimetric Enantioselective Recognition of 3,4-Dihydroxy-d,l-phenylalanine

In pharmaceutical and biomedical applications, it is imperative to identify chiral molecules. However, colorimetric sensing enantiomers relying on chiral nanozymes is still a major challenge in chirality recognition. Herein, we report a facile and simple strategy to prepare copper nanoparticles (CuNPs) using d-cysteine-d-histidine (DCDH), d-cysteine-l-histidine, and l-cysteine-d-histidine as the capping agents. All of these CuNPs exhibited peroxidase-mimicking activity in 3,3',5,5'-tetramethylbenzidine oxidation and presented chiral selectivity toward 3,4-dihydroxy-d,l-phenylalanine (d,l-DOPA). More importantly, DCDH-modified CuNPs (DCDH@CuNPs) showed higher peroxidase-mimicking catalytic activity in the presence of d-DOPA than l-DOPA. This demonstrates that in the stereoselective recognition CuNPs play the catalytic center role and chiral dipeptide ligands play the inducer role. The insights obtained from this study not only provide information to deeply understand the molecular principles of colorimetric chiral recognition upon CuNPs but also guide the design of dipeptide-based chiral nanozymes toward enantiomers.

Supramolecular host-guest interaction-driven electrochemical recognition for pyrophosphate and alkaline phosphatase analysis

Herein, we report an electrochemical biosensor based on the supramolecular host-guest recognition between cucurbit[7]uril (CB[7]) and L -Phenylalanine-Cu(II) Complex for pyrophosphate (PPi) and alkaline phosphatase (ALP) analysis. First, L -Phe-Cu(II) Complex is simply synthesized by the complexation of Cu(II) (metal node) with L -Phe (bioorganic ligand), which can be immobilized onto CB[7] modified electrode via host-guest interaction of CB[7] and L -Phe. In this process, the signal of the Complex triggered electro-catalytic reduction of H 2 O 2 can be captured. Next, in the view of strong chelation between PPi and Cu(II), a biosensing system of the model "PPi and Cu(II) premixing, then adding L -Phe" is designed and the platform can be applied for PPi analysis well by hampering the formation of L -Phe-Cu(II) Complex. Along with ALP introduction, PPi can be hydrolyzed into orthophosphate (Pi), where abundant Cu(II) ions are released to form L -Phe-Cu(II) Complex, which gives rise to the catalytic reaction of Complex to H 2 O 2 reduction. The quantitative analysis of H 2 O 2 , PPi and ALP activity is achieved successfully and the detection of limits are 0.067 μM, 0.42 μM and 0.09 mU/mL ( S / N =3), respectively. With the merits of high sensitivity and selectivity, cost-effectiveness, and simplification, our developed analytical system has great potential to act on diagnosis and treatment of ALP-related diseases.